Table 1. The mNSS scores of rats.
Group | sham-surgery | model | BMSCs | MH | combination therapy |
---|---|---|---|---|---|
Before MCAO | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 |
Before transplantation | 0.00±0.00 | 12.00±1.08 | 11.75±1.23# | 9.92±0.76* | 10.00±0.82* |
1d after transplantation | 0.00±0.00 | 10.50±0.96 | 10.33±1.18# | 8.92±0.95* | 8.00±0.91* |
5d after transplantation | 0.00±0.00 | 8.25±1.01 | 7.42±1.11# | 7.33±1.49# | 5.92±0.86* |
10d after transplantation | 0.00±0.00 | 7.00±1.15 | 5.67±1.03*# | 5.92±1.44*# | 4.42±0.86* |
Neurological functional tests were performed in each group at each time point (n = 6), respectively. The rats mNSS scores in the combination therapy group decreased more obviously than that in the BMSCs group and MH group.
*P<0.05 compared with the model group
#P<0.05, compared with the combination therapy group. Datas were shown as mean±SD